Reverse Medical is a medical device company focused on vascular disease management. Through the acquisition, Covidien will expand its existing portfolio to include vascular technologies to help the company compete in the worldwide vascular embolization market, according to a news release.
Financial terms of the acquisition were not disclosed.
In June, Medtronic entered a definitive agreement to acquire Covidien for $42.9 billion.
More articles on acquisitions:
Roche to buy InterMune for $8.3B
Duke LifePoint, Conemaugh Health reach definitive acquisition agreement
5 recent hospital transactions and partnerships
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.